Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Jan 2022 for Galectin Therapeutics INC, €1,768. Read the official filing
Filing timeline
BuySaleElissa J. Schwartz
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-31.0%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Elissa J. Schwartz: trading record in brief
Only one filing by Elissa J. Schwartz is known so far (24 January 2022): an open-market purchase, €1,768, in Galectin Therapeutics Inc. That is too little to draw conclusions. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Elissa J. Schwartz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
1,000 shares@ US$2.00100.0% of flowCommon StockSEC:0001133416-22-000012:0
Canonical exit: 21 Apr 2022 (T+90)
1 of 1 declaration
